EP1765406A4 - Zuführungsmittel für verbesserte mukosale absorption von therapeutischen mitteln - Google Patents

Zuführungsmittel für verbesserte mukosale absorption von therapeutischen mitteln

Info

Publication number
EP1765406A4
EP1765406A4 EP05764770A EP05764770A EP1765406A4 EP 1765406 A4 EP1765406 A4 EP 1765406A4 EP 05764770 A EP05764770 A EP 05764770A EP 05764770 A EP05764770 A EP 05764770A EP 1765406 A4 EP1765406 A4 EP 1765406A4
Authority
EP
European Patent Office
Prior art keywords
agents
mucosal absorption
delivery
enhancing mucosal
therapeutic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05764770A
Other languages
English (en)
French (fr)
Other versions
EP1765406A1 (de
Inventor
Youngro Buyn
Hyuntae Moon
Seulki Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mediplex Corp Korea
Original Assignee
Mediplex Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/851,477 external-priority patent/US7906137B2/en
Application filed by Mediplex Corp Korea filed Critical Mediplex Corp Korea
Publication of EP1765406A1 publication Critical patent/EP1765406A1/de
Publication of EP1765406A4 publication Critical patent/EP1765406A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP05764770A 2004-05-21 2005-05-10 Zuführungsmittel für verbesserte mukosale absorption von therapeutischen mitteln Withdrawn EP1765406A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/851,477 US7906137B2 (en) 2004-05-21 2004-05-21 Delivery agents for enhancing mucosal absorption of therapeutic agents
KR1020050008137A KR100679677B1 (ko) 2004-05-21 2005-01-28 생물학적 활성제의 점막흡수 증강을 위한 전달제
PCT/KR2005/001359 WO2005113008A1 (en) 2004-05-21 2005-05-10 Delivery agents for enhancing mucosal absorption of therapeutic agents

Publications (2)

Publication Number Publication Date
EP1765406A1 EP1765406A1 (de) 2007-03-28
EP1765406A4 true EP1765406A4 (de) 2012-11-28

Family

ID=35428257

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05764770A Withdrawn EP1765406A4 (de) 2004-05-21 2005-05-10 Zuführungsmittel für verbesserte mukosale absorption von therapeutischen mitteln

Country Status (2)

Country Link
EP (1) EP1765406A4 (de)
WO (1) WO2005113008A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
MX349677B (es) 2007-11-13 2017-08-08 Meritage Pharma Inc Composiciones corticosteroides.
FR2925333B1 (fr) * 2007-12-19 2012-04-13 Farid Bennis Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
CA2857502C (en) 2011-11-30 2019-08-13 3M Innovative Properties Company Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same
CN105408343B (zh) 2013-06-06 2018-08-03 耶路撒冷希伯来大学伊森姆研究发展有限公司 胆汁酸-碱性氨基酸缀合物及其用途
IL310069A (en) 2015-04-29 2024-03-01 Radius Pharmaceuticals Inc Cancer treatment methods
WO2018129419A1 (en) 2017-01-05 2018-07-12 Radius Pharmaceuticals, Inc. Polymorphic forms of rad1901-2hcl
PE20211202A1 (es) 2017-08-24 2021-07-05 Novo Nordisk As Composiciones de glp-1 y sus usos
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541348A (en) * 1994-03-10 1996-07-30 National Research Council Of Canada Bile acids for biological and chemical applications and processes for the production thereof
US6395713B1 (en) * 1997-07-23 2002-05-28 Ribozyme Pharmaceuticals, Inc. Compositions for the delivery of negatively charged molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850001573B1 (ko) * 1984-01-13 1985-10-19 주식회사 대웅제약 아미노산 축합 담즙산의 제조방법
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
ATE152729T1 (de) * 1993-03-09 1997-05-15 Hoechst Ag Verfahren zur herstellung von 3beta- aminocholansäurederivaten
IT1313617B1 (it) * 1999-08-31 2002-09-09 Bracco Spa Processo per la preparazione di derivati degli acidi biliari.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541348A (en) * 1994-03-10 1996-07-30 National Research Council Of Canada Bile acids for biological and chemical applications and processes for the production thereof
US6395713B1 (en) * 1997-07-23 2002-05-28 Ribozyme Pharmaceuticals, Inc. Compositions for the delivery of negatively charged molecules

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARYN LANG BOWE ET AL: "Design of compounds that increase the absorption of polar molecules", PROC. NATL. ACAD. SCI. USA, 1 October 1997 (1997-10-01), pages 12218 - 12223, XP055041853, Retrieved from the Internet <URL:http://www.pnas.org/content/94/22/12218.full.pdf#page=1&view=FitH> [retrieved on 20121022] *
See also references of WO2005113008A1 *
SINGLETARY W V ET AL: "Ileal transport of bile acids conjugated with norleucine and lysine", BIOCHIMICA ET BIOPHYSICA ACTA. BIOMEMBRANES, AMSTERDAM, NL, vol. 266, no. 1, 14 April 1972 (1972-04-14), pages 238 - 245, XP023792797, ISSN: 0005-2736, [retrieved on 19720414], DOI: 10.1016/0005-2736(72)90138-1 *

Also Published As

Publication number Publication date
EP1765406A1 (de) 2007-03-28
WO2005113008A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
EP1730148A4 (de) Aminobenzoxazole als therapeutische mittel
EP1765406A4 (de) Zuführungsmittel für verbesserte mukosale absorption von therapeutischen mitteln
GB0416396D0 (en) Therapeutic agents
GB0419850D0 (en) Therapeutic agents
GB0403780D0 (en) Therapeutic agents
GB0419192D0 (en) Therapeutic agents
GB0423103D0 (en) Therapeutic agents
GB0400193D0 (en) Therapeutic agents
GB0417939D0 (en) Therapeutic agents
GB0427701D0 (en) Therapeutic agents
GB0417560D0 (en) Therapeutic compounds
GB0400196D0 (en) Therapeutic agents
GB0428075D0 (en) Therapeutic agents
GB0403779D0 (en) Therapeutic agents
GB0416934D0 (en) Therapeutic agents
GB0402918D0 (en) Therapeutic agents
GB0406432D0 (en) Therapeutic agents
GB0410855D0 (en) Therapeutic agents
GB0402526D0 (en) Therapeutic agents
GB0400231D0 (en) Therapeutic agents
GB0400195D0 (en) Therapeutic agents
GB0400198D0 (en) Therapeutic agents
GB0420781D0 (en) Therapeutic agents
GB0420780D0 (en) Therapeutic agents
GB0428073D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061220

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LEE, SEULKI

Inventor name: BUYN, YOUNGRO

Inventor name: MOON, HYUNTAE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LEE, SEULKI

Inventor name: MOON, HYUNTAE

Inventor name: BUYN, YOUNGRO

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121029

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/14 20060101AFI20121023BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121201